Total planned funding: $213,823,586
Allocations
Countries/Regions
India | $213,823,586 |
Organizational Types
Unknown | $104,213,388 |
NGO | $52,936,859 |
Own Agency | $27,560,542 |
University | $16,390,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,406,808 |
Host Country Government Agency | $1,610,200 |
FBO | $1,100,000 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $84,316,422 |
Prevention | $52,544,607 |
Care | $28,383,421 |
Management and Operations | $22,482,763 |
Testing | $12,108,212 |
Treatment | $9,560,369 |
Budget Codes
OHSS: Health Systems Strengthening | $51,704,331 |
HVOP: Sexual Prevention: Other Sexual Prevention | $28,586,472 |
HVSI: Strategic Information | $27,232,526 |
HVMS: Management and Operations | $22,482,763 |
HBHC: Care: Adult Care and Support | $20,072,220 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,202,434 |
HVCT: Testing: HIV Testing and Counseling | $12,108,212 |
HTXS: Treatment: Adult Treatment | $9,180,098 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,263,081 |
HKID: Care: Orphans and Vulnerable Children | $5,684,276 |
HLAB: Laboratory Infrastructure | $5,379,565 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,452,379 |
HVTB: Care: TB/HIV | $2,366,908 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $356,794 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$103,165,899
Countries/Regions
USG Aggregated Agencies:
$18,188,527
Countries/Regions
FHI 360:
$18,182,311
Countries/Regions
Voluntary Health Services:
$10,140,000
Countries/Regions